377 related articles for article (PubMed ID: 25236477)
1. Arterial spin labeling MRI: clinical applications in the brain.
Telischak NA; Detre JA; Zaharchuk G
J Magn Reson Imaging; 2015 May; 41(5):1165-80. PubMed ID: 25236477
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
3. Mapping of cerebral perfusion territories using territorial arterial spin labeling: techniques and clinical application.
Hartkamp NS; Petersen ET; De Vis JB; Bokkers RP; Hendrikse J
NMR Biomed; 2013 Aug; 26(8):901-12. PubMed ID: 22807022
[TBL] [Abstract][Full Text] [Related]
4. Arterial spin-labeling MR imaging of cerebral hemorrhages.
Noguchi T; Nishihara M; Egashira Y; Azama S; Hirai T; Kitano I; Yakushiji Y; Kawashima M; Irie H
Neuroradiology; 2015 Nov; 57(11):1135-44. PubMed ID: 26280515
[TBL] [Abstract][Full Text] [Related]
5. Superselective arterial spin labeling applied for flow territory mapping in various cerebrovascular diseases.
Helle M; Rüfer S; van Osch MJ; Nabavi A; Alfke K; Norris DG; Jansen O
J Magn Reson Imaging; 2013 Aug; 38(2):496-503. PubMed ID: 23526786
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
Wong AM; Yan FX; Liu HL
J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
[TBL] [Abstract][Full Text] [Related]
7. Brain perfusion territory imaging: methods and clinical applications of selective arterial spin-labeling MR imaging.
van Laar PJ; van der Grond J; Hendrikse J
Radiology; 2008 Feb; 246(2):354-64. PubMed ID: 18227536
[TBL] [Abstract][Full Text] [Related]
8. Multi-phase 3D arterial spin labeling brain MRI in assessing cerebral blood perfusion and arterial transit times in children at 3T.
Hu HH; Rusin JA; Peng R; Shao X; Smith M; Krishnamurthy R; Selvaraj B; Wang DJJ
Clin Imaging; 2019; 53():210-220. PubMed ID: 30439588
[TBL] [Abstract][Full Text] [Related]
9. Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease.
Gevers S; Nederveen AJ; Fijnvandraat K; van den Berg SM; van Ooij P; Heijtel DF; Heijboer H; Nederkoorn PJ; Engelen M; van Osch MJ; Majoie CB
J Magn Reson Imaging; 2012 Apr; 35(4):779-87. PubMed ID: 22095695
[TBL] [Abstract][Full Text] [Related]
10. A Short Introduction to Arterial Spin Labeling and its Application to Flow Territory Mapping.
Lindner T; Helle M; Jansen O
Clin Neuroradiol; 2015 Oct; 25 Suppl 2():211-8. PubMed ID: 26308246
[TBL] [Abstract][Full Text] [Related]
11. Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET).
van Golen LW; Kuijer JP; Huisman MC; IJzerman RG; Barkhof F; Diamant M; Lammertsma AA
J Magn Reson Imaging; 2014 Dec; 40(6):1300-9. PubMed ID: 24214919
[TBL] [Abstract][Full Text] [Related]
12. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
13. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
[TBL] [Abstract][Full Text] [Related]
14. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
[TBL] [Abstract][Full Text] [Related]
15. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of cerebral blood flow in multiple sclerosis: a pseudocontinuous arterial spin labeling MRI study.
Ota M; Sato N; Nakata Y; Ito K; Kamiya K; Maikusa N; Ogawa M; Okamoto T; Obu S; Noda T; Araki M; Yamamura T; Kunugi H
Magn Reson Imaging; 2013 Jul; 31(6):990-5. PubMed ID: 23582984
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular MRI: a review of state-of-the-art approaches, methods and techniques.
MacDonald ME; Frayne R
NMR Biomed; 2015 Jul; 28(7):767-91. PubMed ID: 26010775
[TBL] [Abstract][Full Text] [Related]
18. Arterial spin labeling perfusion MRI in children and young adults with previous ischemic stroke and unilateral intracranial arteriopathy.
Bulder MM; Bokkers RP; Hendrikse J; Kappelle LJ; Braun KP; Klijn CJ
Cerebrovasc Dis; 2014; 37(1):14-21. PubMed ID: 24355934
[TBL] [Abstract][Full Text] [Related]
19. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
[TBL] [Abstract][Full Text] [Related]
20. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
